Janney Starts Marinus Pharmaceuticals (MRNS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
- Oppenheimer sees AI software winners as focus shifts to ROI
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
JMP Securities Starts Marinus Pharmaceuticals (MRNS) at Market Outperform
August 26, 2014 8:23 AM EDTJMP Securities initiated coverage on Marinus Pharmaceuticals (NASDAQ: MRNS) with a Market Outperform rating and a price target of $14.00.
For an analyst ratings summary and ratings history on Marinus Pharmaceuticals click here. For more ratings news on Marinus Pharmaceuticals click here.
Shares of Marinus Pharmaceuticals closed at $8.04 yesterday.
... MoreStifel Nicolaus Starts Marinus Pharmaceuticals (MRNS) at Buy
August 25, 2014 7:15 AM EDTStifel Nicolaus initiated coverage on Marinus Pharmaceuticals (NASDAQ: MRNS) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Marinus Pharmaceuticals click here. For more ratings news on Marinus Pharmaceuticals click here.
Shares of Marinus Pharmaceuticals closed at $8.04 yesterday.
... More